Health Care

Fortrea Holdings Inc. readies Q4 earnings amid healthcare innovation buzz—expect a rebound, positive EPS, and growth prospects for the Nasdaq‑listed biotech services firm.

Perimeter Medical Imaging AI Inc. powers real‑time tissue imaging, boosting diagnostic accuracy for healthcare and mining sectors. Explore its TSX growth potential.

Gerresheimer AG announces Goldman Sachs holds 10%+ voting rights, ensuring full European transparency and reinforcing investor confidence in its pharma‑glass business.

Conexeu Sciences: volatile NYSE stock, $3.65 close, 52‑week high $18.79, focused on regenerative skin‑restoration therapies—high‑risk, high‑reward biotech opportunity.

BioNTech’s latest mRNA cancer trial fails to hit PFS targets, but the company’s robust cash reserve and long‑term pipeline keep investors watching for future breakthroughs.

Explore how Novo Nordisk navigates talent loss, supply‑chain risks and a booming biologics market, staying ahead with AI‑driven research and robust financials.

Explore Arcutis Biotherapeutics: a leading biotech in immune‑mediated disease treatments, its market growth, and future innovation strategies.

Winklevoss family remains top shareholder of biotech firm Cypherpunk Technologies after latest Form 4 filing, while CIO William McEvoy boosts stake, signaling stability and growth prospects.

Tonix Pharma reports strong Q3 revenue and a robust cash position, while unveiling its TNX‑801 vaccine platform at the World Vaccine Congress and advancing CNS therapies.

Pfizer’s 2026 earnings reveal a 226% payout and a 36.7× trailing P/E, yet the company is poised to thrive amid a looming biosimilar boom and patent expiries.